Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.
about
Risk factors for osteoporosis in inflammatory bowel disease patientsBone and TNF in rheumatoid arthritis: clinical implicationsBiologic therapies and bone loss in rheumatoid arthritis.Bisphosphonates and glucocorticoid-induced osteoporosis: cons.OsteoRheumatology: a new discipline?Glucocorticoids: bad or safe for the bones?Long-term treatment of rheumatoid arthritis with adalimumab.Management of osteoporosis in rheumatoid arthritis patients.Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats.The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss.Decreased quantity and quality of the periarticular and nonperiarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study.Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.Re-evaluating osteoporosis and fracture risk in Crohn's disease patients in the era of TNF-alpha inhibitors.Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort.Are glucocorticoids harmful to bone in early rheumatoid arthritis?
P2860
Q26776142-245F2980-88E6-4402-BB24-28CE62D6F7E8Q26777895-E445F10B-D783-4B72-A23F-1B7B16F08C73Q30243911-96BF4D37-00D4-444A-895A-4F6D6A833A92Q35882427-0D32B5F5-81DF-4A46-91F7-89D7608D6841Q36246080-89287B6E-B951-4AD7-B6AD-E9191A225C20Q36246088-D01DC467-83B3-4EE1-BC22-715431778527Q37358278-5427252E-5A95-48C7-AD23-754E7F42D241Q38334318-44F641B3-C402-449B-8A91-29F388F7D13FQ38792812-D69FD306-522A-40C8-9FC2-23DD618867BAQ38831693-7341703A-2C72-498B-9B11-6B1FDE0A3E7EQ38904535-F8A49CDB-CBAF-4204-9012-3C22088B015BQ41236945-1A33ED09-B8FA-4343-AAAC-D5033ED70D03Q44303831-6D754A6B-C502-4DD3-BE97-A3550F60888DQ46671185-4F027A1A-9BF2-4AB7-BD71-53E42C48D15BQ47110800-58E17D5C-BC8F-4A43-BF50-5E01AE7FC1EBQ47174371-1288E57C-7367-466B-BD34-DA047519E124Q48503661-357EEF56-06C5-4069-8DC2-582DDAE09AC7Q51741238-866D5539-78B0-4D92-A1F0-B03B78B9B356
P2860
Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Changes in bone mineral densit ...... oid arthritis: a cohort study.
@en
type
label
Changes in bone mineral densit ...... oid arthritis: a cohort study.
@en
prefLabel
Changes in bone mineral densit ...... oid arthritis: a cohort study.
@en
P2093
P2860
P356
P1433
P1476
Changes in bone mineral densit ...... oid arthritis: a cohort study.
@en
P2093
Charlotte L M Krieckaert
Gertjan Wolbink
Michael T Nurmohamed
Willem F Lems
P2860
P304
P356
10.1093/RHEUMATOLOGY/KES320
P577
2012-12-05T00:00:00Z